Kobe, Japan

Tatsuzo Ukita

This inventor holds 8 USPTO granted patents. Top assignees: Tanabe Seiyaku Company, Limited, Mitsubishi Tanabe Pharma Corporation. Active years: 1999-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuzo Ukita. Retrieved from https://idiyas.com/inventor/tatsuzo-ukita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1999-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Tatsuzo Ukita

Introduction

Tatsuzo Ukita is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 8 patents to his name, Ukita's work has had a considerable impact on medicinal chemistry.

Latest Patents

Among his latest innovations, Ukita has developed condensed polycyclic compounds that serve as phosphodiesterase 4 inhibitors. These compounds are represented by a specific formula and can be utilized in pharmaceutical compositions. His research focuses on creating effective treatments that can improve patient outcomes.

Career Highlights

Throughout his career, Tatsuzo Ukita has worked with notable companies such as Tanabe Seiyaku Company, Limited and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Ukita has collaborated with esteemed colleagues, including Katsuo Ikezawa and Yoshihiro Terakawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Tatsuzo Ukita's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…